|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| G01N 33/15 | |||
| C12Q 1/68 | |||
| A61P 35/00 |
| (11) | Number of the document | 2524232 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11733335.1 |
| Date of filing the European patent application | 2011-01-12 | |
| (97) | Date of publication of the European application | 2012-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/021026 |
| Date | 2011-01-12 |
| (87) | Number | WO 2011/088149 |
| Date | 2011-07-21 |
| (30) | Number | Date | Country code |
| 351838 P | 2010-06-04 | US | |
| 328602 P | 2010-04-27 | US | |
| 325624 P | 2010-04-19 | US | |
| 294433 P | 2010-01-12 | US |
| (72) |
LIU, Xinjun, US
KIM, Phillip, US
KIRKLAND, Richard, US
LEE, Tani, US
YBARRONDO, Belen, US
SINGH, Sharat, US
|
| (73) |
Nestec S.A.,
Avenue Nestlé 55, 1800 Vevey,
CH
|
| (54) | METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY |
| METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY |